July 2025 in “JOJ Dermatology & Cosmetics” Both treatments improved hair quality and thickness equally, with mild side effects.
March 2025 in “Journal of Cutaneous and Aesthetic Surgery” Non-laser devices show promise in treating hair issues, but more research is needed.
February 2025 in “Healthcare” Caffeine may help with hair loss, but more research is needed.
Combined oral minoxidil and finasteride significantly improve hair density in men with male pattern baldness.
August 2024 in “Frontiers in Nutrition” Antioxidant-rich diets may reduce hair loss risk, while pro-inflammatory diets may increase it, especially in women.
September 2023 in “International Journal of Trichology” Early treatment of Folliculitis Decalvans in children can improve inflammation and partially regrow hair.
January 2023 in “Journal of surgery and research” New treatment effectively reverses hair thinning in most patients with mild side effects.
January 2023 in “Springer eBooks” Hair shedding that lasts over 6 months may need a closer look, but often just reassurance is enough.
April 2026 in “Antibodies” The role of antibodies in alopecia is unclear, but JAK inhibitors show promise for treatment.
September 2025 in “Journal of Drug Delivery Science and Technology” Vitamin D3-coated nanoparticles effectively deliver caffeine for alopecia treatment with minimal side effects.
January 2023 in “Dermatologic Therapy” The new 5% minoxidil foam is as effective and safe as Rogaine® for treating hair loss in Chinese men.
January 2022 in “Springer eBooks” 81 citations
,
December 2007 in “Acta materialia” AFM helped show how hair changes under tension and the effects of damage and conditioner.
9 citations
,
June 2016 in “Stem cells” Overexpression of sPLA2-IIA in mouse skin reduces hair stem cells and increases cell differentiation through JNK/c-Jun pathway activation.
2 citations
,
July 2023 in “Cosmetics” Surfactants in shampoos and conditioners remove some but not all lipids from hair, and more research is needed to understand their full impact.
March 2026 in “Pharmaceutics” TheDES improve drug delivery through the skin but need more safety checks.
Scarring alopecia, a type of hair loss, is most common in females under 35, often caused by discoid lupus erythematosus and pseudopelade of Brocq. Skin punch biopsy and histopathology are key to identifying its cause.
May 2026 in “Case Reports in Dermatology” This document discusses a case of a 31-year-old kidney transplant recipient who developed significant alopecia due to tacrolimus-based immunosuppression. The hair loss had a psychological impact, leading the patient to consider stopping treatment. A switch to cyclosporine A improved hair regrowth and well-being. A literature review identified four similar cases linking alopecia to immunosuppressive therapy in organ transplant recipients. The study emphasizes the importance of awareness among clinicians about hair disorders as side effects of immunosuppression, which can affect treatment adherence and quality of life. Regular dermatological assessments and personalized management, including adjusting immunosuppressive regimens, are recommended to mitigate these issues.
A coordinated approach combining medical, trichological, and visual support is needed to better manage hair loss.
December 2025 in “International Journal of Advanced Biochemistry Research” Malvi cattle hair varies in color and pattern across different body regions.
January 2024 in “Estetologia Medyczna i Kosmetologia” Most hair loss shampoos have unproven active ingredients.
The product made from plant extracts was tested for treating hair loss caused by genetics.
This document discusses a case of a 31-year-old kidney transplant recipient who developed significant alopecia due to tacrolimus-based immunosuppression. The hair loss had a psychological impact, leading the patient to consider stopping treatment. Dermatological evaluation showed androgenetic alopecia and telogen effluvium. Switching from tacrolimus to cyclosporine A improved hair regrowth and well-being. A literature review found four similar cases linking alopecia to immunosuppressive therapy in organ transplant recipients. The study emphasizes the importance of awareness of hair disorders in transplant patients, suggesting regular dermatological assessments and potential adjustments in immunosuppressive regimens to improve patient quality of life and treatment adherence.
This document discusses a case of a 31-year-old kidney transplant recipient who developed significant alopecia due to tacrolimus-based immunosuppression. The hair loss had a psychological impact, leading the patient to consider stopping treatment. A switch to cyclosporine A improved hair regrowth and well-being. A literature review found four similar cases linking alopecia to immunosuppressive therapy in organ transplant recipients. The study emphasizes the importance of recognizing hair disorders as side effects of immunosuppression, which can affect treatment adherence and quality of life. Regular dermatological assessments and personalized management, including adjusting immunosuppressive regimens, are recommended to mitigate these issues.
January 2026 in “Aesthetic Cosmetology and Medicine” Effective scalp problem treatment needs a comprehensive approach.
January 2025 in “Journal of Ayurveda and Integrated Medical Sciences” A holistic lifestyle and ethical practices are key to managing hair disorders and improving well-being.
1 citations
,
January 2015 in “International journal of trichology (Print)” A single long white eyelash is a rare but benign condition.
February 2026 in “Middle European Scientific Bulletin” Improving scalp microbiome may help restore hair and improve scalp health.
April 2026 in “Academia Polonica.” Alopecia in women can signal broader health issues and requires a thorough diagnosis to tailor treatments.